Clinical trial
Randomized Placebo-Controlled Trial of Glutamine for Breast Cancer Patients With…
NCT00195013 · Weill Medical College of Cornell University, Other · Completed
Key facts
| NCT number | NCT00195013 |
|---|---|
| Title | Randomized Placebo-Controlled Trial of Glutamine for Breast Cancer Patients With Peripheral Neuropathy |
| Official title | A Randomized Placebo-controlled Trial of Glutamine to Reduce the Signs and Symptoms of Peripheral Neuropathy in Breast Cancer Patients With a Mild Peripheral Neuropathy Receiving Paclitaxel Chemotherapy |
| Lead sponsor | Weill Medical College of Cornell University, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Peripheral Neuropathy, Breast Cancer |
| Intervention type | Drug |
| Interventions | glutamine, Placebo |
| Enrollment | 30 |
| Start date | Dec 1, 2003 |
| Primary completion | May 1, 2014 |
| Completion | May 1, 2014 |
| First posted | Sep 19, 2005 |
| Last update posted | Jun 6, 2018 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: